Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

DQ 2511

Known as: DQ-2511 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
We examined the implication of a nitric oxide (NO)-guanosine 3',5'-cyclic monophosphate (cGMP) cascade in the suppression of… Expand
1996
1996
We compared the main pharmacological effect of DQ‐2511 (3‐[[[2‐(3,4‐dimethoxyphenyl)‐ethyl]carbamoyl]methyl]amino ‐N… Expand
1996
1996
1. DQ-2511 is a new substituted benzamide compound that has gastric prokinetic properties. Actions of the drug on neural… Expand
1996
1996
A previous study revealed that DQ-2511, a new gastroprokinetic drug, induced hemolytic anemia together with increased Heinz body… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
1996
1996
Intracellular recording of electrical and synaptic behavior of neurons in the enteric nervous system of guinea-pig small… Expand
1995
1995
The present study was designed to clarify the potential of DQ-2511 (3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]carbamoyl]methyl… Expand
1995
1995
The pharmacological characteristics of DQ-2511, a substituted benzamide (3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl… Expand
1995
1995
It has been reported that 3-(([2-(3,4-dimethoxyphenyl)ethyl]carbamoyl)methyl)amino-N-methylbenz amide (DQ-2511: ecabapide… Expand
1993
1993
DQ-2511, a new anti-ulcer drug, was administered to beagle dogs for 4 weeks to investigate the mechanism whereby this drug… Expand
1992
1992
A series of acyl derivatives of 2-(3,4-dimethoxyphenyl)ethylamine (4) were synthesized and evaluated for their effectiveness to… Expand